

Author: Mendes R. Poncio Negroni R. Bonifaz A. Pappagianis D.
Publisher: Informa Healthcare
ISSN: 1460-2709
Source: Medical Mycology, Vol.38, Iss.1, 2000-12, pp. : 237-241
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The treatment of mycetomas varies according to their etiological agents and the clinical state of the patient. For the treatment of eumycetomas, the azole derivatives are the drugs of choice, with itraconazole rendering better results than ketoconazole and presenting better tolerance. Actinomycetomas are treated according to different therapeutic schemes: dapsone plus sulfamethoxazol-trimethoprim (SMT), and streptomycin or amikacin or amoxicillin plus clavulanic acid. The first therapeutic scheme is very useful in the treatment of
Related content


By Verweij P. E. Figueroa J. Burik J. van Holdom M. D. Dei-Cas E. Gómez B. L. Mendes-Giannini M. J.
Medical Mycology, Vol. 38, Iss. 1, 2000-12 ,pp. :




By Dupont B. Brown H. H. Crewe Westermann K. Martins M. D. Rex J. H. Lortholary O. Kauffmann C. A.
Medical Mycology, Vol. 38, Iss. 1, 2000-12 ,pp. :


By Stevens DA Walsh TJ. Bistoni F. Cenci E. Clemons KV. Del Sero G. Fè D'Ostiani C. Kullberg BJ. Mencacci A. Roilides E. Romani L.
Medical Mycology, Vol. 36, Iss. 6, 1998-12 ,pp. :


Some aspects of cellulose biosynthesis
By Finaev D.
Biologia Plantarum, Vol. 51, Iss. 3, 2007-09 ,pp. :